188 related articles for article (PubMed ID: 24949562)
1. Altered discharges of spinal neurons parallel the behavioral phenotype shown by rats with bortezomib related chemotherapy induced peripheral neuropathy.
Robinson CR; Zhang H; Dougherty PM
Brain Res; 2014 Jul; 1574():6-13. PubMed ID: 24949562
[TBL] [Abstract][Full Text] [Related]
2. Astrocytes, but not microglia, are activated in oxaliplatin and bortezomib-induced peripheral neuropathy in the rat.
Robinson CR; Zhang H; Dougherty PM
Neuroscience; 2014 Aug; 274():308-17. PubMed ID: 24905437
[TBL] [Abstract][Full Text] [Related]
3. Mitotoxicity and bortezomib-induced chronic painful peripheral neuropathy.
Zheng H; Xiao WH; Bennett GJ
Exp Neurol; 2012 Dec; 238(2):225-34. PubMed ID: 22947198
[TBL] [Abstract][Full Text] [Related]
4. Gabapentin inhibits bortezomib-induced mechanical allodynia through supraspinal action in mice.
Kitamura R; Andoh T; Mizoguchi S; Saito Y; Takahata H; Kuraishi Y
J Pharmacol Sci; 2014; 124(4):502-10. PubMed ID: 24681698
[TBL] [Abstract][Full Text] [Related]
5. Responses of primary afferents and spinal dorsal horn neurons to thermal and mechanical stimuli before and during zymosan-induced inflammation of the rat hindpaw.
Randich A; Meller ST; Gebhart GF
Brain Res; 1997 Oct; 772(1-2):135-48. PubMed ID: 9406965
[TBL] [Abstract][Full Text] [Related]
6. Spinal astrocyte gap junction and glutamate transporter expression contributes to a rat model of bortezomib-induced peripheral neuropathy.
Robinson CR; Dougherty PM
Neuroscience; 2015 Jan; 285():1-10. PubMed ID: 25446343
[TBL] [Abstract][Full Text] [Related]
7. Bortezomib treatment produces nocifensive behavior and changes in the expression of TRPV1, CGRP, and substance P in the rat DRG, spinal cord, and sciatic nerve.
Quartu M; Carozzi VA; Dorsey SG; Serra MP; Poddighe L; Picci C; Boi M; Melis T; Del Fiacco M; Meregalli C; Chiorazzi A; Renn CL; Cavaletti G; Marmiroli P
Biomed Res Int; 2014; 2014():180428. PubMed ID: 24877063
[TBL] [Abstract][Full Text] [Related]
8. Bortezomib-induced painful peripheral neuropathy: an electrophysiological, behavioral, morphological and mechanistic study in the mouse.
Carozzi VA; Renn CL; Bardini M; Fazio G; Chiorazzi A; Meregalli C; Oggioni N; Shanks K; Quartu M; Serra MP; Sala B; Cavaletti G; Dorsey SG
PLoS One; 2013; 8(9):e72995. PubMed ID: 24069168
[TBL] [Abstract][Full Text] [Related]
9. Bortezomib-induced severe autonomic neuropathy.
Stratogianni A; Tosch M; Schlemmer H; Weis J; Katona I; Isenmann S; Haensch CA
Clin Auton Res; 2012 Aug; 22(4):199-202. PubMed ID: 22532274
[TBL] [Abstract][Full Text] [Related]
10. Bortezomib-induced painful neuropathy in rats: a behavioral, neurophysiological and pathological study in rats.
Meregalli C; Canta A; Carozzi VA; Chiorazzi A; Oggioni N; Gilardini A; Ceresa C; Avezza F; Crippa L; Marmiroli P; Cavaletti G
Eur J Pain; 2010 Apr; 14(4):343-50. PubMed ID: 19695912
[TBL] [Abstract][Full Text] [Related]
11. Role of a pre-existing neuropathy on the course of bortezomib-induced peripheral neurotoxicity.
Lanzani F; Mattavelli L; Frigeni B; Rossini F; Cammarota S; Petrò D; Jann S; Cavaletti G
J Peripher Nerv Syst; 2008 Dec; 13(4):267-74. PubMed ID: 19192066
[TBL] [Abstract][Full Text] [Related]
12. Follow-up psychophysical studies in bortezomib-related chemoneuropathy patients.
Boyette-Davis JA; Cata JP; Zhang H; Driver LC; Wendelschafer-Crabb G; Kennedy WR; Dougherty PM
J Pain; 2011 Sep; 12(9):1017-24. PubMed ID: 21703938
[TBL] [Abstract][Full Text] [Related]
13. Nociceptive response to innocuous mechanical stimulation is mediated via myelinated afferents and NK-1 receptor activation in a rat model of neuropathic pain.
Pitcher GM; Henry JL
Exp Neurol; 2004 Apr; 186(2):173-97. PubMed ID: 15026255
[TBL] [Abstract][Full Text] [Related]
14. Bortezomib-induced neuropathy: axonal membrane depolarization precedes development of neuropathy.
Nasu S; Misawa S; Nakaseko C; Shibuya K; Isose S; Sekiguchi Y; Mitsuma S; Ohmori S; Iwai Y; Beppu M; Shimizu N; Ohwada C; Takeda Y; Fujimaki Y; Kuwabara S
Clin Neurophysiol; 2014 Feb; 125(2):381-7. PubMed ID: 23973385
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of peripheral neuropathy associated with bortezomib and vincristine in patients with newly diagnosed multiple myeloma: a prospective analysis of data from the HOVON-65/GMMG-HD4 trial.
Broyl A; Corthals SL; Jongen JL; van der Holt B; Kuiper R; de Knegt Y; van Duin M; el Jarari L; Bertsch U; Lokhorst HM; Durie BG; Goldschmidt H; Sonneveld P
Lancet Oncol; 2010 Nov; 11(11):1057-65. PubMed ID: 20864405
[TBL] [Abstract][Full Text] [Related]
16. Altered discharges of spinal wide dynamic range neurons and down-regulation of glutamate transporter expression in rats with paclitaxel-induced hyperalgesia.
Cata JP; Weng HR; Chen JH; Dougherty PM
Neuroscience; 2006; 138(1):329-38. PubMed ID: 16361064
[TBL] [Abstract][Full Text] [Related]
17. Bortezomib-induced peripheral neuropathy in multiple myeloma: a comprehensive review of the literature.
Argyriou AA; Iconomou G; Kalofonos HP
Blood; 2008 Sep; 112(5):1593-9. PubMed ID: 18574024
[TBL] [Abstract][Full Text] [Related]
18. Behavioral and electrophysiological studies in rats with cisplatin-induced chemoneuropathy.
Cata JP; Weng HR; Dougherty PM
Brain Res; 2008 Sep; 1230():91-8. PubMed ID: 18657527
[TBL] [Abstract][Full Text] [Related]
19. Frequency, characteristics, and reversibility of peripheral neuropathy during treatment of advanced multiple myeloma with bortezomib.
Richardson PG; Briemberg H; Jagannath S; Wen PY; Barlogie B; Berenson J; Singhal S; Siegel DS; Irwin D; Schuster M; Srkalovic G; Alexanian R; Rajkumar SV; Limentani S; Alsina M; Orlowski RZ; Najarian K; Esseltine D; Anderson KC; Amato AA
J Clin Oncol; 2006 Jul; 24(19):3113-20. PubMed ID: 16754936
[TBL] [Abstract][Full Text] [Related]
20. Impact of dose modification on intravenous bortezomib-induced peripheral neuropathy in multiple myeloma patients.
Cho J; Kang D; Lee JY; Kim K; Kim SJ
Support Care Cancer; 2014 Oct; 22(10):2669-75. PubMed ID: 24771302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
